Congenital Hearing Loss
8
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (8)
Investigating the Neural Oscillatory Features for Limited Access to Oral Language in Deaf Children With Early Bilateral Cochlear Implantation
Cochlear Implants in Young Children With SSD
Perceptual Evaluation and Rehabilitation System Development for Congenital Hearing Loss
A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss
a Study in Subjects With Otoferlin Mutation-related Hearing Loss Using RNA Base-eDiting Therapy(SOUND)
Communities Helping the Hearing of Infants by Reaching Parents
Genetic Feature of Congenital Hearing Loss in Chinese Population
Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators